CAPRICOR THERAPEUTICS, INC.
Net SellingCAPR·US·🇺🇸 US
0%buys·100%sells
19 transactions$0Total buys·0 buys
$5.3MTotal sells·5 sells
33 insiders
Last: Apr 2, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 2, 26 | Sabar Karimah Es | Exercise | - | |
| Apr 2, 26 | Sabar Karimah Es | Sell | $241K | |
| Apr 2, 26 | Sabar Karimah Es | Exercise | $24K | |
| Apr 1, 26 | Sabar Karimah Es | Exercise | - | |
| Apr 1, 26 | Sabar Karimah Es | Sell | $1.7M | |
| Apr 1, 26 | Sabar Karimah Es | Exercise | $261K | |
| Mar 31, 26 | Bergmann Anthony | Exercise | - | |
| Mar 31, 26 | Bergmann Anthony | Sell | $753K | |
| Mar 31, 26 | Bergmann Anthony | Exercise | $80K | |
| Mar 31, 26 | Krasney Karen | Exercise | - |
Bergmann Anthony (CFO) recently executed a sell of $753K in CAPRICOR THERAPEUTICS, INC. shares on March 31, 2026. Overall insider sentiment is bearish (100% sales).
CAPRICOR THERAPEUTICS, INC. (CAPR) has recorded 19 insider operations, including 0 open-market purchases ($0), 5 sales ($5.3M) and 14 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (100% sales).
Recent activity is concentrated over 2 months in the last year.
Among the most active insiders are Bergmann Anthony (CFO), Sabar Karimah Es (BOARD MEMBER) & Krasney Karen (SENIOR EXECUTIVE), with respectively 35, 20, 38 transactions.
Across all 19 recorded transactions, the breakdown by type is: exercise (14, 74%), sells (5, 26%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
CAPRICOR THERAPEUTICS, INC. has recorded 19 insider operations in total, including 0 open-market purchases ($0), 5 sales ($5.3M) and 14 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 2, 2026.
Insiders at CAPRICOR THERAPEUTICS, INC. are currently net sellers, with 0% purchases and 100% sales across all reported transactions. Total buy volume is $0 versus $5.3M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 3 insiders at CAPRICOR THERAPEUTICS, INC. (CAPR). Bergmann Anthony (CFO, 35 tx), Sabar Karimah Es (BOARD MEMBER, 20 tx), Krasney Karen (SENIOR EXECUTIVE, 38 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for CAPR is bearish, based on a 0% buy ratio across 5 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for CAPRICOR THERAPEUTICS, INC. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.